All News about Bio-Rad Laboratories
![](/next-assets/images/schema-image-default.png)
Earnings Outlook For Bio-Rad Laboratories
October 25, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Tuesday's After-Market Session
October 17, 2023
Via Benzinga
![](https://mms.businesswire.com/media/20231005466163/en/618489/22/Logo_RGB_on_transpar.jpg)
![](https://investorplace.com/wp-content/uploads/2022/06/biotechnologyepzm1600.png)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
The Latest Analyst Ratings for Bio-Rad Laboratories
August 04, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
The Latest Analyst Ratings for Bio-Rad Laboratories
June 16, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Recap: Bio-Rad Laboratories Q1 Earnings
May 04, 2023
Via Benzinga
![](https://mms.businesswire.com/media/20230828364522/en/618489/22/Logo_RGB_on_transpar.jpg)
![](https://mms.businesswire.com/media/20230803001058/en/618489/22/Logo_RGB_on_transpar.jpg)
Bio-Rad Reports Second-Quarter 2023 Financial Results
August 03, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20230726552882/en/1851185/22/qiagen-logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/07/21/evlo.png?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Golden Cross Appears Before Bio-Rad Laboratories Investors
March 10, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_111.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230720208629/en/618489/22/Logo_RGB_on_transpar.jpg)
Bio-Rad Announces New Share Repurchase Program
July 20, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20230710399913/en/618489/22/Logo_RGB_on_transpar.jpg)
![](https://mms.businesswire.com/media/20230710228837/en/618489/22/Logo_RGB_on_transpar.jpg)
Via Business Wire
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://mms.businesswire.com/media/20230601005365/en/618489/22/Logo_RGB_on_transpar.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/05/11/image42.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230508005225/en/618489/22/Logo_RGB_on_transpar.jpg)
![](https://schaeffers-cdn.s3.amazonaws.com/images/default-source/schaeffers-cdn-images/2023/may/may/midday-market-stats-may-52023.png?sfvrsn=fbeaa06_2)
![](https://cdn.benzinga.com/files/images/story/2023/05/05/atlassian_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230504005499/en/943541/22/5056532cLogo_RGB_on_transpar.jpg)
Bio-Rad Reports First-Quarter 2023 Financial Results
May 04, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20230412005752/en/618489/4/Logo_RGB_on_transpar.jpg)
![](https://investorplace.com/wp-content/uploads/2020/09/biotech-stocks.jpg)
![](https://investorplace.com/wp-content/uploads/2022/10/electric-vehicle-charging-ev-1600.jpg)
![](https://mms.businesswire.com/media/20230217005088/en/618489/4/Logo_RGB_on_transpar.jpg)
![](https://mms.businesswire.com/media/20230216005696/en/942681/22/Logo_RGB_on_transpar.jpg)
Bio-Rad Reports Fourth-Quarter and Full-Year 2022 Financial Results
February 16, 2023
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.